Quantitative and Qualitative Disclosures about Market Risk
−Removed: Our balance sheet as of December 31, 2019 includes cash and cash equivalents of $32,426.
+Added: Interest Rate Risk .
+Added: As of December 31, 2020, we had $213,119 cash and cash equivalents.
+Added: Our cash and cash equivalents is primarily held in U.S.
+Added: Government money market funds.
We do not participate in any foreign currency hedging activities and we do not have any other derivative financial instruments.
3 unchanged sentences
In addition, we maintain significant amounts of cash at one or more financial institutions that are in excess of federally insured limits.
−Removed: Inflation generally affects us by increasing our cost of labor and clinical trial costs.
−Removed: We do not believe that inflation has had a material effect on our results of operations during the periods presented.
+Added: Capital Market Risk .
+Added: We currently have no product revenues and depend on funds raised through other sources.
+Added: One source of funding is through future debt or equity offerings.
+Added: Our ability to raise funds in this manner depends upon, among other things, capital market forces affecting our stock price, and on the state of the capital markets generally.
Financial Statements and Supplementary Data
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.